Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06208748
Title SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sarcoma Alliance for Research through Collaboration
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST